65 related articles for article (PubMed ID: 7474409)
1. A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.
Thomas A; Rajan A; Szabo E; Tomita Y; Carter CA; Scepura B; Lopez-Chavez A; Lee MJ; Redon CE; Frosch A; Peer CJ; Chen Y; Piekarz R; Steinberg SM; Trepel JB; Figg WD; Schrump DS; Giaccone G
Clin Cancer Res; 2014 Nov; 20(21):5392-402. PubMed ID: 25189481
[TBL] [Abstract][Full Text] [Related]
2. Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study.
Kirzinger L; Boy S; Marienhagen J; Schuierer G; Neu R; Ried M; Hofmann HS; Wiebe K; Ströbel P; May C; Kleylein-Sohn J; Baierlein C; Bogdahn U; Marx A; Schalke B
PLoS One; 2016; 11(12):e0168215. PubMed ID: 27992479
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced thymoma and thymic carcinoma.
Rajan A; Giaccone G
Curr Treat Options Oncol; 2008 Dec; 9(4-6):277-87. PubMed ID: 19381821
[TBL] [Abstract][Full Text] [Related]
4. A rare highly aggressive tumour: lymphoepithelioma-like thymic carcinoma.
Gomez JMD; Syed G; Co MLF; Bayoumi M; Abrams R
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28942409
[TBL] [Abstract][Full Text] [Related]
5. Epithelial thymic tumours in paediatric age: a report from the TREP project.
Carretto E; Inserra A; Ferrari A; Conte M; Di Cataldo A; Migliorati R; Cecchetto G; Bisogno G
Orphanet J Rare Dis; 2011 May; 6():28. PubMed ID: 21600006
[TBL] [Abstract][Full Text] [Related]
6. Drastic response to rechallenge with calboplatin plus nab-paclitaxel after immunotherapy in a patient with advanced thymic carcinoma.
Fujita T; Amano H; Nakamura M; Ishikawa R; Inazaki T; Urano Y; Hirano S; Nakamura S
Respir Investig; 2023 Jul; 61(4):508-510. PubMed ID: 37267851
[No Abstract] [Full Text] [Related]
7. Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma.
Kaira K; Imai H; Kagamu H
Lung Cancer; 2024 Mar; 189():107501. PubMed ID: 38342048
[No Abstract] [Full Text] [Related]
8. Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report.
Gharwan H; Tomita Y; Lee MJ; Thomas A; Berman A; Giaccone G; Trepel J; Rajan A
Oncol Lett; 2015 Aug; 10(2):1155-1158. PubMed ID: 26622643
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
10. Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma.
Kaira K; Imai H; Yamaguchi O; Mouri A; Kagamu H
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771601
[TBL] [Abstract][Full Text] [Related]
11. The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature.
Pettit L; El-Modir A
Br J Radiol; 2011 Jan; 84(997):e7-e10. PubMed ID: 21172961
[TBL] [Abstract][Full Text] [Related]
12. A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management.
Lee HS; Kim ST; Lee J; Choi YS; Han JH; Ahn YC; Lee KS; Ahn JS; Ahn MJ; Kim K; Shim YM; Kim J; Park K
Br J Cancer; 2007 Jul; 97(1):22-8. PubMed ID: 17592498
[TBL] [Abstract][Full Text] [Related]
13. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
14. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
Jpn J Clin Oncol; 1995 Oct; 25(5):203-7. PubMed ID: 7474408
[TBL] [Abstract][Full Text] [Related]
15. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of thymoma].
Monden Y; Uyama T; Kimura S; Takahashi K
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2019-24. PubMed ID: 2221924
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.
Kitami A; Suzuki T; Kamio Y; Suzuki S
Jpn J Clin Oncol; 2001 Dec; 31(12):601-4. PubMed ID: 11902491
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
